Trump et al. focus on NIH, cancer—and how peer review is done

Trump targets HHS in $810M appropriations clawback

President Donald Trump has moved to cancel $810 million in government spending that has already been appropriated by Congress.

NIH introduces “Linked Discoveries,” a PubMed tool aimed at strengthening research replication, reproducibility

NIH has introduced Linked Discoveries, an experimental tool designed to help scientists more easily see how an individual research finding relates to the larger body of biomedical evidence.

October 02, 2026

Vol.52 No.36

News Analysis

Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants

The White House last week considered, but ultimately abandoned, a plan to create a panel that would review NIH grants in an effort to weed out projects the administration regards as “woke.”

HHS issues direct final rule to reduce reliance on animal testing

FDA has issued a direct final rule that changes the language in its regulations so that “animal testing” is no longer described as the default or defining form of “nonclinical” safety testing.

September 25, 2026

Vol.52 No.35

By Claire Marie Porter

In Brief

Ronald McDonald Community Floor opens in honor of Childhood Cancer Awareness Month

Ronald McDonald House New York announced the completion of its renovation of the Community Floor, a reimagined space designed to enhance the everyday experience of children and families staying at the House while their children receive treatment for serious illnesses. The project, which has transformed dining, kitchen, play, and program areas on the second floor of the House at 405 East 73rd Street, creates spaces where families can share meals, children can play and learn, and caregivers can find opportunities for connection, respite, and support.

September 25, 2026

Vol.52 No.35

In Brief

UCLA researchers receive $7M NIH grant to launch trial for immunotherapy-related diabetes

UCLA researchers have received a grant worth up to $7 million over five years from the National Institute of Allergy and Infectious Diseases to launch a first-in-human clinical trial evaluating whether drugs already used to treat autoimmune diseases can prevent or reverse immune checkpoint inhibitor-induced type 1 diabetes, a rare but often permanent complication of cancer immunotherapy.

September 18, 2026

Vol.52 No.34

Trump et al. focus on NIH, cancer—and how peer review is done

YOU MAY BE INTERESTED IN

Trump targets HHS in $810M appropriations clawback

NIH introduces “Linked Discoveries,” a PubMed tool aimed at strengthening research replication, reproducibility

Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants

HHS issues direct final rule to reduce reliance on animal testing

Ronald McDonald Community Floor opens in honor of Childhood Cancer Awareness Month

UCLA researchers receive $7M NIH grant to launch trial for immunotherapy-related diabetes

Renew today!

Subscriber content

Never miss an issue!

Login